Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hormones play an important role in pathophysiology. The hormone receptors, such as estrogen receptor alpha and androgen receptor in breast cancer and prostate cancer, are critical to cancer cell proliferation and tumor growth. In this review we focused on the cross-talk between hormone and hypoxia pathways, particularly in breast cancer. We delineated a novel signaling pathway from estrogen receptor to hypoxia-inducible factor 1, and discussed the role of this pathway in endocrine therapy resistance. Further, we discussed the estrogen and hypoxia pathways converging at histone demethylase KDM4B, an important epigenetic modifier in cancer.

Original publication

DOI

10.3390/ijms19010240

Type

Journal article

Journal

Int J Mol Sci

Publication Date

13/01/2018

Volume

19

Keywords

KDM4B, endocrine therapy resistance, estrogen receptor alpha, hypoxia-inducible factor 1, Animals, Base Sequence, Cell Hypoxia, Estrogens, Humans, Jumonji Domain-Containing Histone Demethylases, Models, Biological, Neoplasms, Signal Transduction